Cytokine Plasma Levels, HCMV Antigenemia, and HCMV Disease in Renal Allograft Recipients Treated With OKT3 MoAb and PTX in Combination or OKT3 MoAb Alone
| Patient . | TNFα Plasma Peak Level (pg/mL) . | IL-6 Plasma Peak Level (pg/mL) . | HCMV Antigenemia . | HCMV Disease . | Fever (d 1-3) . | 
|---|---|---|---|---|---|
| OKT3 MoAB/PTX | |||||
| No 1 | 225 | 12 | + | + | + | 
| No 2 | 1,382 | 125 | + | + | + | 
| No 3 | 226 | 23 | + | + | + | 
| No 4 | 270 | 25 | − | − | + | 
| (median) | (median) | ||||
| Total | 248 | 24 | 3/4 | 3/4 | 4/4 | 
| OKT3 MoAb | |||||
| No 5 | 854 | 225 | + | + | + | 
| No 6 | 1,029 | 245 | + | − | + | 
| No 7 | 1,211 | 491 | − | − | + | 
| (median) | (median) | ||||
| Total | 1,029 | 245 | 2/3 | 1/3 | 3/3 | 
| Patient . | TNFα Plasma Peak Level (pg/mL) . | IL-6 Plasma Peak Level (pg/mL) . | HCMV Antigenemia . | HCMV Disease . | Fever (d 1-3) . | 
|---|---|---|---|---|---|
| OKT3 MoAB/PTX | |||||
| No 1 | 225 | 12 | + | + | + | 
| No 2 | 1,382 | 125 | + | + | + | 
| No 3 | 226 | 23 | + | + | + | 
| No 4 | 270 | 25 | − | − | + | 
| (median) | (median) | ||||
| Total | 248 | 24 | 3/4 | 3/4 | 4/4 | 
| OKT3 MoAb | |||||
| No 5 | 854 | 225 | + | + | + | 
| No 6 | 1,029 | 245 | + | − | + | 
| No 7 | 1,211 | 491 | − | − | + | 
| (median) | (median) | ||||
| Total | 1,029 | 245 | 2/3 | 1/3 | 3/3 |